Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Musculoskeletal Transplant Foundation, Inc.
EIR
•Musculoskeletal Transplant Foundation, Inc.•March 9, 2022

Musculoskeletal Transplant Foundation, Inc. – FDA EIR, Mar 9, 2022

Record Details

The FDA conducted a routine, comprehensive inspection of Musculoskeletal Transplant Foundation, Inc. (MTF Biologics) in Edison, NJ, from February 28 to March 9, 2022. This inspection focused on Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) under the relevant regulatory framework. Notably, the current inspection concluded without any significant deficiencies being identified or an FDA Form 483 being issued. The report indicated that previously identified deficiencies from a 2017-2018 inspection, which concerned Zika virus screening and documentation, had been fully corrected. Minor issues noted during this inspection were rectified on-site. While this specific inspection was favorable, the document detailed a history of the company's internal nonconformance reports and recalls, demonstrating ongoing compliance efforts. These included issues like incorrect media preparation for sterility testing, failure to place tissue on hold, and the presence of particulates (stainless steel and rubber) in prehydrated adipose products, which led to enhanced preventive maintenance and procedural updates. Recent recalls, some classified as Class 1, stemmed from errors in quality review processes regarding non-conforming organisms, and issues with donor eligibility assessments, including cases of sepsis and updated donor risk information. MTF Biologics implemented extensive corrective actions for these incidents, such as revising procedures, reconfiguring computer systems, and comprehensive staff retraining, to prevent recurrence and ensure product safety.

Company
Musculoskeletal Transplant Foundation, Inc.
Inspection date
March 9, 2022
Product type
Biologics
Office
Office of Biological Product Operations
People
  • Raymond Ferrara (company_representative)
  • Timothy Alcid (company_representative)
  • Christopher J. Adams
  • Sarah M. Forney (investigator)
  • Joel Osborne (company_representative)
View Company Profile

ID · 234dc994-0c80-4106-b83e-2a59d2ccd01f

Violation Codes1
21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for Musculoskeletal Transplant Foundation, Inc.
  • 483 - 2021-11-17November 17, 2021
  • 483 - 2014-05-19May 19, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Musculoskeletal Transplant Foundation, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.